Literature DB >> 20382115

Fab MAbs specific to HA of influenza virus with H5N1 neutralizing activity selected from immunized chicken phage library.

Pannamthip Pitaksajjakul1, Porntippa Lekcharoensuk, Narin Upragarin, Carlos F Barbas, Madiha Salah Ibrahim, Kazuyoshi Ikuta, Pongrama Ramasoota.   

Abstract

Hemagglutinin protein (HA) was considered to be the primary target for monoclonal antibody production. This protein not only plays an important role in viral infections, but can also be used to differentiate H5N1 virus from other influenza A viruses. Hence, for diagnostic and therapeutic applications, it is important to develop anti-HA monoclonal antibody (MAb) with high sensitivity, specificity, stability, and productivity. Nine unique Fab MAbs were generated from chimeric chicken/human Fab phage display library constructed from cDNA derived from chickens immunized with recombinant hemagglutinin protein constructed from H5N1 avian influenza virus (A/Vietnam/1203/04). The obtained Fab MAbs showed several characteristics for further optimization and development-three clones were highly specific to only H5N1 virus. This finding can be applied to the development of H5N1 diagnostic testing. Another clone showed neutralization activity that inhibited H5N1 influenza virus infection in Madin-Darby canine kidney (MDCK) cells. In addition, one clone showed strong reactivity with several of the influenza A virus subtypes tested. The conversion of this clone to whole IgG is a promising study for a cross-neutralization activity test. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20382115     DOI: 10.1016/j.bbrc.2010.04.040

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Phage display--a powerful technique for immunotherapy: 2. Vaccine delivery.

Authors:  Justyna Bazan; Ireneusz Całkosiński; Andrzej Gamian
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

2.  Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses.

Authors:  W W Shanaka I Rodrigo; Juan C de la Torre; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

Review 3.  Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.

Authors:  Kristian Daniel Ralph Roth; Esther Veronika Wenzel; Maximilian Ruschig; Stephan Steinke; Nora Langreder; Philip Alexander Heine; Kai-Thomas Schneider; Rico Ballmann; Viola Fühner; Philipp Kuhn; Thomas Schirrmann; André Frenzel; Stefan Dübel; Maren Schubert; Gustavo Marçal Schmidt Garcia Moreira; Federico Bertoglio; Giulio Russo; Michael Hust
Journal:  Front Cell Infect Microbiol       Date:  2021-07-07       Impact factor: 5.293

4.  Mimotopes selected with neutralizing antibodies against multiple subtypes of influenza A.

Authors:  Yanwei Zhong; Jiong Cai; Chuanfu Zhang; Xiaoyan Xing; Enqiang Qin; Jing He; Panyong Mao; Jun Cheng; Kun Liu; Dongping Xu; Hongbin Song
Journal:  Virol J       Date:  2011-12-15       Impact factor: 4.099

5.  Generation and analysis of the improved human HAL9/10 antibody phage display libraries.

Authors:  Jonas Kügler; Sonja Wilke; Doris Meier; Florian Tomszak; André Frenzel; Thomas Schirrmann; Stefan Dübel; Henk Garritsen; Björn Hock; Lars Toleikis; Mark Schütte; Michael Hust
Journal:  BMC Biotechnol       Date:  2015-02-19       Impact factor: 2.563

Review 6.  Phage display for the generation of antibodies for proteome research, diagnostics and therapy.

Authors:  Thomas Schirrmann; Torsten Meyer; Mark Schütte; André Frenzel; Michael Hust
Journal:  Molecules       Date:  2011-01-10       Impact factor: 4.411

Review 7.  Avian IgY antibodies and their recombinant equivalents in research, diagnostics and therapy.

Authors:  Edzard Spillner; Ingke Braren; Kerstin Greunke; Henning Seismann; Simon Blank; Dion du Plessis
Journal:  Biologicals       Date:  2012-06-28       Impact factor: 1.856

8.  Diagnostic Potential of Recombinant scFv Antibodies Generated Against Hemagglutinin Protein of Influenza A Virus.

Authors:  Roopali Rajput; Gaurav Sharma; Varsha Rawat; Anju Gautam; Binod Kumar; B Pattnaik; H K Pradhan; Madhu Khanna
Journal:  Front Immunol       Date:  2015-09-02       Impact factor: 7.561

Review 9.  Recombinant Antibodies in Veterinary Medicine: An Update.

Authors:  Lorena Bustamante-Córdova; Edgar A Melgoza-González; Jesús Hernández
Journal:  Front Vet Sci       Date:  2018-07-27

Review 10.  Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.

Authors:  Philipp Kuhn; Viola Fühner; Tobias Unkauf; Gustavo Marcal Schmidt Garcia Moreira; André Frenzel; Sebastian Miethe; Michael Hust
Journal:  Proteomics Clin Appl       Date:  2016-06-21       Impact factor: 3.494

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.